Follow The Filings

AMSF AMERISAFE

AMERISAFE earnings company data as of 7:57 PM ET 11/4

  • 0 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 0.47 0.39 Miss -17.0%
Rev $84.2M $79.8M Miss -5.2%

Insider trades

Open-market buys and sales by AMSF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AMSF insider trades
  • None no insider bought on the open market
  • $100K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Anastasios Omiridis CFO
    Sale
    $50K 1,247 shares at $40.21 33% of stake
    Traded Nov 20, 2025 Filed Nov 20, 2025
    ↗
  2. Anastasios Omiridis CFO
    Sale
    $50K 1,235 shares at $40.74 25% of stake
    Traded Nov 7, 2025 Filed Nov 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 11 stock grants, 9 share withholdings for taxes, and 5 option exercises.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf